Webcast ImageWebcast
Q3 2014 Incyte Corporation Earnings Conference Call (Live)
10/30/14 at 8:30 a.m. ET
Q3 2014 Incyte Corporation Earnings Conference Call
Thursday, October 30, 2014 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

The field of oncology is evolving rapidly and transforming how cancer is treated. We believe Incyte, rooted in rigorous science, is at the center of this transformation. Our pipeline includes innovative compounds in three major oncology areas: onco-inflammation, immuno-oncology and targeted therapies.

We believe our professional and financial resources, our experience and our prior success in bringing important new drugs to market put us in a strong position to make a difference in health care, improve the lives of patients and build sustainable value for our shareholders.


Recent News More >>
DateTitle 
October 23, 2014Incyte to Present at the Nomura BioPharma Conference
WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 23, 2014-- Incyte Corporation (Nasdaq:INCY) announced today it will present at the Nomura BioPharma Conference on Thursday, November 6, 2014 at 1:15 p.m. (EST) in Boston. The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available. Investors interested in listening to the live webcast should ... 
Printer Friendly Version
October 17, 2014Incyte Appoints David Gryska as Executive Vice President and Chief Financial Officer
WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 17, 2014-- Incyte Corporation (NASDAQ: INCY) today announced the appointment of David Gryska as Executive Vice President and Chief Financial Officer, effective October 31, 2014. Mr. Gryska will report to Hervé Hoppenot, President and Chief Executive Officer. Mr. Gryska will succeed David Hastings, who has served as Incyte’s Executive Vice President and Chief Financial Officer since October 2003. Mr. ... 
Printer Friendly Version
October 15, 2014Incyte to Report Third Quarter 2014 Financial Results on October 30
WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 15, 2014-- Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its third quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, October 30, 2014. The schedule for the press release and conference call is as follows:           ... 
Printer Friendly Version

2013 Annual Report
2013 Annual Report Download Documentation

2013 10-K

Notice To Readers: Incyte's press releases, presentations and printed remarks are included on this Web site for historical purposes only. The information contained in these documents and webcasts should be considered accurate only as of the date of the relevant document or presentation. This information may change over time; therefore, visitors to this Web site should not assume that the information contained in these documents or presentations remains accurate at a later time. We do not have any current intention, and expressly disclaim any obligation, to supplement, update or revise any of the information in these documents or presentations.


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.